ARDELYX, INC. Basic Shares Outstanding (Weighted Average)
ARDELYX, INC. (ARDX) reported Basic Shares Outstanding (Weighted Average) of 248.07 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- ARDELYX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 248.07M shares, a 3.39% increase year-over-year.
- ARDELYX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 245.86M shares, a 3.03% increase year-over-year.
- ARDELYX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 243.64M shares, a 2.63% increase year-over-year.
- ARDELYX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 241.91M shares, a 2.54% increase year-over-year.
- ARDELYX, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 241.03M shares, a 2.47% increase from fiscal 2024.
- ARDELYX, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 235.23M shares, a 7.25% increase from fiscal 2023.
- ARDELYX, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 219.33M shares, a 38.21% increase from fiscal 2022.
- ARDELYX, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 158.69M shares, a 52.29% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 248.07M shares 10-Q · filed 2026-08-06 | 246.97M shares 10-Q · filed 2026-08-06 | 245.85M shares derived: average of 3 quarters · filed 2026-08-06 | 244.87M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 245.86M shares 10-Q · filed 2026-04-30 | 244.75M shares derived: average of 2 quarters · filed 2026-04-30 | 243.80M shares derived: average of 3 quarters · filed 2026-04-30 | 242.83M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 243.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 242.77M shares derived: average of 2 quarters · filed 2026-02-19 | 241.82M shares derived: average of 3 quarters · filed 2026-08-06 | 241.03M shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 241.91M shares 10-Q · filed 2025-10-30 | 240.92M shares derived: average of 2 quarters · filed 2026-08-06 | 240.17M shares 10-Q · filed 2025-10-30 | 239.46M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 239.93M shares 10-Q · filed 2026-08-06 | 239.28M shares 10-Q · filed 2026-08-06 | 238.65M shares derived: average of 3 quarters · filed 2026-08-06 | 237.96M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 238.62M shares 10-Q · filed 2026-04-30 | 238.00M shares derived: average of 2 quarters · filed 2026-04-30 | 237.31M shares derived: average of 3 quarters · filed 2026-04-30 | 236.62M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 237.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 236.65M shares derived: average of 2 quarters · filed 2026-02-19 | 235.96M shares derived: average of 3 quarters · filed 2026-02-19 | 235.23M shares 10-K · filed 2026-02-19 |
| 2024-09-30 | 235.91M shares 10-Q · filed 2025-10-30 | 235.24M shares derived: average of 2 quarters · filed 2025-10-30 | 234.52M shares 10-Q · filed 2025-10-30 | 233.99M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | 234.57M shares 10-Q · filed 2025-08-04 | 233.82M shares 10-Q · filed 2025-08-04 | 233.34M shares derived: average of 3 quarters · filed 2026-02-19 | 230.70M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | 233.07M shares 10-Q · filed 2025-05-01 | 232.73M shares derived: average of 2 quarters · filed 2026-02-19 | 229.41M shares derived: average of 3 quarters · filed 2026-02-19 | 225.80M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | 232.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 227.59M shares derived: average of 2 quarters · filed 2026-02-19 | 223.38M shares derived: average of 3 quarters · filed 2026-02-19 | 219.33M shares 10-K · filed 2026-02-19 |
| 2023-09-30 | 222.78M shares 10-Q · filed 2024-10-31 | 218.87M shares derived: average of 2 quarters · filed 2024-10-31 | 214.98M shares 10-Q · filed 2024-10-31 | 209.39M shares derived: average of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | 214.95M shares 10-Q · filed 2024-08-01 | 211.01M shares 10-Q · filed 2024-08-01 | 204.93M shares derived: average of 3 quarters · filed 2025-02-20 | 194.97M shares derived: average of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | 207.02M shares 10-Q · filed 2024-05-02 | 199.91M shares derived: average of 2 quarters · filed 2025-02-20 | 188.31M shares derived: average of 3 quarters · filed 2025-02-20 | 177.62M shares derived: average of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | 192.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | 178.95M shares derived: average of 2 quarters · filed 2025-02-20 | 167.82M shares derived: average of 3 quarters · filed 2025-02-20 | 158.69M shares 10-K · filed 2025-02-20 |
| 2022-09-30 | 165.10M shares 10-Q · filed 2023-10-31 | 155.32M shares derived: average of 2 quarters · filed 2023-10-31 | 147.32M shares 10-Q · filed 2023-10-31 | 139.24M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 145.54M shares 10-Q · filed 2023-08-02 | 138.28M shares 10-Q · filed 2023-08-02 | 130.62M shares derived: average of 3 quarters · filed 2024-02-22 | 124.00M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 130.93M shares 10-Q · filed 2023-05-03 | 123.16M shares derived: average of 2 quarters · filed 2024-02-22 | 116.82M shares derived: average of 3 quarters · filed 2024-02-22 | 112.63M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | 115.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 109.76M shares derived: average of 2 quarters · filed 2024-02-22 | 106.52M shares derived: average of 3 quarters · filed 2024-02-22 | 104.21M shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 104.14M shares 10-Q · filed 2022-11-03 | 102.09M shares derived: average of 2 quarters · filed 2022-11-03 | 100.48M shares 10-Q · filed 2022-11-03 | 98.09M shares derived: average of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | 100.04M shares 10-Q · filed 2022-08-04 | 98.62M shares 10-Q · filed 2022-08-04 | 96.07M shares derived: average of 3 quarters · filed 2023-03-02 | 94.40M shares derived: average of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | 97.18M shares 10-Q · filed 2022-05-05 | 94.09M shares derived: average of 2 quarters · filed 2023-03-02 | 92.51M shares derived: average of 3 quarters · filed 2023-03-02 | 91.66M shares derived: average of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | 91.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 90.18M shares derived: average of 2 quarters · filed 2023-03-02 | 89.82M shares derived: average of 3 quarters · filed 2023-03-02 | 89.58M shares 10-K · filed 2023-03-02 |
| 2020-09-30 | 89.37M shares 10-Q · filed 2021-11-12 | 89.22M shares derived: average of 2 quarters · filed 2021-11-12 | 89.11M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 89.08M shares 10-Q · filed 2021-08-13 | 88.89M shares 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | 88.88M shares 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 64.48M shares 10-K · filed 2022-02-28 | |||
| 2016-06-30 | 34.64M shares 10-Q · filed 2016-08-08 | 34.05M shares 10-Q · filed 2016-08-08 | ||
| 2015-09-30 | 25.93M shares 10-Q · filed 2015-11-12 | 23.41M shares derived: average of 2 quarters · filed 2016-08-08 | 21.86M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 20.88M shares 10-Q · filed 2016-08-08 | 19.75M shares 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | 18.61M shares 10-Q · filed 2015-05-12 | |||
| 2014-09-30 | 18.37M shares 10-Q · filed 2015-11-12 | 10.49M shares derived: average of 2 quarters · filed 2015-11-12 | 7.48M shares 10-Q · filed 2015-11-12 | |
| 2014-06-30 | 2.61M shares 10-Q · filed 2015-08-12 | 1.94M shares 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | 1.26M shares 10-Q · filed 2015-05-12 | |||
| 2013-09-30 | 1.16M shares 10-Q · filed 2014-11-07 | 1.13M shares derived: average of 2 quarters · filed 2014-11-07 | 1.10M shares 10-Q · filed 2014-11-07 | |
| 2013-06-30 | 1.10M shares 10-Q · filed 2014-08-08 | 1.07M shares 10-Q · filed 2014-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |